SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.330
+0.650 (17.66%)
Jan 23, 2025, 4:00 PM EST - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $287.68 million as of January 23, 2025. Its market cap has decreased by -14.57% in one year.
Market Cap
287.68M
Enterprise Value
218.25M
1-Year Change
-14.57%
Ranking
Category
Stock Price
$4.33
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $287.68M, a decrease of -74.32%. That is a compound annual growth rate of -32.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2025 | 287.68M | 41.04% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.06B |
| UnitedHealth Group | 482.43B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 353.31B |
| AbbVie | 298.10B |
| Merck & Co. | 241.93B |
| Thermo Fisher Scientific | 216.67B |
| Intuitive Surgical | 214.70B |